mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)

Author： Prajapati H. J.   Spivey J. R.   Hanish S. I.   El-Rayes B. F.   Kauh J. S.   Chen Z.   Kim H. S.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 965-973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in nonviral hepatocellular carcinoma treated with transarterial chemoembolization

By          

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1704-1710

Spandidos Publications

Access to resources Recommend Favorite

Three (3) Cases of Advanced HepatocellularCarcinoma (HCC) Treated Successfully by Transcatheter Arterial Chemoembolization (TACE) Using Lipiodol and a Fine Powder Formulated Cisplatin (DDPH)

By Kasai Kazuhiro   Kuroda Hidekatsu   Ushio Akira   Miyamoto Yasuhiro   Sawara Kei   Miyasaka Aikio   Takikawa Yasuhiro   Suzuki Kazuyuki  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 479-483

Sunmedia

Access to resources Recommend Favorite

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study

By Luo Jun  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 413-420

Springer Publishing Company

Access to resources Recommend Favorite

Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicineluting beads compared with lipiodol

By                  

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1377-1383

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib in combination with transarterial chemoembolization in Chinese patients with hepatocellular carcinoma: a subgroup interim analysis of the START trial

By Han Guohong   Yang Jijin   Shao Guoliang   Teng Gaojun   Wang Maoqiang   Yang Jianyong   Liu Zhaoyu   Feng Gansheng   Yang Renjie   Lu Ligong   Chao Yee   Wang Jianhua  

Future Oncology, Vol. 9, Iss. 3, 2013-03 ,pp. : 403-410

Future Medicine

Access to resources Recommend Favorite